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Purpose: Intimal hyperplasia caused by smooth muscle cell (SMC) proliferation is the 
major cause of infrainguinal graft failure within the first 12 months. Tobacco smoking is 
associated with a twofold increase in graft failure within the first year of extremity bypass 
surgery, but the mechanism is not clearly understood. This study evaluated the effect of 
nicotine and its major stable metabolite cotinine on vascular SMC proliferation in vitro. 
Methods: SMC were harvested from human arteries and grown in culture with standard 
methods. Cells were seeded at a density of 1.8 x 104 cells/well in 24 multiwell dishes and 
cell cycle-synchronized. Subsequently the SMC were incubated with media containing 
0.1% or 15% fetal bovine serum and nicotine or cotinine at concentrations ranging from 
10 -9  mol /L  to 10 -6 mol/L.  Control samples were incubated with corresponding media 
but without the drugs. SMC proliferation was determined at 4 days with a cell counter. 
DNA synthesis was assessed at 24 hours with SH-thymidine uptake. The results were 
expressed as a percentage change compared with the control samples (mean _+ SEM). 
Results were analyzed by analysis of variance and t tests. 
Results: In the presence of serum both nicotine and cotinine at concentrations of 10 -7 
and 10 -8 mol /L  were mitogenic for SMC in vitro (p < 0.05). A weak mitogenic effect 
was observed at a low serum concentration for cotinine but not nicotine. Cotinine at a 
concentration of 10 -9  mol/L,  a level seen among passive smokers, was a statistically 
significant stimulus for DNA synthesis in both minimum serum and serum-supplemented 
media. At high concentrations both substances were toxic for the cells. 
Conclusion: We have demonstrated a potential role for nicotine and cotinine in the 
development of intimal hyperplasia and ultimately failure of the vascular reconstruction. 
(J Vasc Surg I997;25:682-8.) 
One in six deaths in the United States is related to 
cigarette smoking. ~ Excessive mortality rates from 
tobacco has been mainly attributed to increased inci- 
dence of  coronary heart disease, chronic obstructive 
lung disease, and cancer of the lung, larynx, mouth, 
esophagus, pancreas, and bladder. 2,3 The high inci- 
dence of cigarette smokers among patients with clau- 
dication was first reported almost 100 years ago. 4 
However, the direct link between cigarette smoking 
and atherosclerosis became widely accepted first after 
the report by Juergens et al.s that showed that more 
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than 75% of  men with lower extremity atherosclero- 
sis were smokers. Several others confirmed the role of 
cigarette smoking in the development of atheroscle- 
rosis. 6,7 More recently it has been shown that smok- 
ing has a negative ffect on graft patency after both 
aortofemoral and infrainguinal arterial reconstruc- 
tions. 8,9 The mechanism by which cigarette smoking 
negatively affects graft patency after vascular econ- 
struction is not clearly understood. The failure of 
infrainguinal reconstruction within the first year after 
surgery is most often caused by the formation of in- 
ritual hyperplasia resulting from smooth muscle cell 
(SMC) proliferation in the graft itself. It  has been 
well documented that as a result of  injury of  the 
vessel or dysfunction of  the endothelium, SMC in 
the tunica media become highly sensitive to the che- 
motactic and mitogenic influence ofplatelet-derived 
growth factor and fibroblast growth factor. ~° SMC 
subsequently migrate to the intima and proliferate 
there for an unknown period of  time, often dramati- 
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Fig. 1. DNA synthesis in synchronized human smooth muscle cell culture after 24 hours of 
incubation with different concentrations of nicotine or cotinine dissolved in medium M199 
supplemented with 0.1% fetal bovine serum. Values indicate percent of 3H thymidine incorpo- 
ration compared with values obtained with M199 supplemented with 0.1% fetal bovine serum 
in absence of nicotine or cotinine. Values represent mean of three to five observations, with 
+SEM indicated by vertical bars (*p < 0.05). 
cally increasing the thickness of  the vessel wall. This 
study was designed to determine whether nicotine or 
cotinine have a direct stimulatory effect on human 
SMC proliferation i  vitro. 
MATERIAL  AND METHODS 
Materials. Nicotine and cotinine were pur- 
chased from Sigma Chemical (St. Louis, Mo.). 
M199 medium, fetal bovine serum (FBS), vitamins, 
minimal essential amino acids, penicillin-streptomy- 
cin mixture, gentamycin, trypsin, calcium, and mag- 
nesium-free Dulbecco's phosphate buffer saline solu- 
tion (PBS) were obtained from Life Technologies 
(Grand Island, N.Y.). Insulin, transferrin, and sele- 
nium mixture were from Sigma. Monoclonal anti- 
bodies against ct and 13 actins were from Sigma. 
Monoclonal antibodies against von Willebrand factor 
were purchased from Biogenex (San Roman, Calif.). 
Tissue culture dishes were from Becton-Dickinson 
(Lincoln Park, N.Y.). 
Cell cultures. Human aortic and iliac artery 
SMC were isolated from macroscopically healthy ves- 
sels of cadaver donors and characterized aspreviously 
described. 11 In brief, the endothelial layer from the 
vessel was denuded, and 1 mm 2 strips of vessel wall 
were cut out and put in 100 mm dishes (precoated 
with collagen) for 2 hours at 37 ° C and 5% CO 2. 
After the small tissue pieces had adhered, M199 
containing 15% heat-inactivated FBS, 1% vitamins, 
1% essential amino acid, 0.5% penicillin-streptomycin 
mixture, 0.02% gentamycin, 5 tLg/ml insulin, 5 
Ixg/ml transferrin, 0.005 txg/ml selenium (growth 
media [GM]) was added. Within 2 weeks SMC had 
migrated from the explants, at which point the tissue 
pieces were removed. At confluency the cells were 
detached by treatment of  0.05% trypsin/0.02% eth- 
ylenediamine t traacetic acid solution for 5 minutes 
at 37 ° C and were reseeded in T-12 flasks. The cells 
were grown to confluency in M199 containing 15% 
FBS, antibiotics mixture, vitamins, and essential 
amino acids at 37 ° C and 5% CO2 and were split at a 
ratio of  1:3. Cultures were routinely fed every 48 
hours. The experiments described in this work were 
conducted on cells between passages 2 to 6. 
Cell characterizations. The cell cultures were 
characterized by immunoperoxidase taining with 
monoclonal antibodies against 0t and 13 actins and 
monoclonal antibody to human von Willebrand fac- 
tor. The SMC were seeded into 96-well plates and 
grown to confluency. The cells were then washed, 
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Fig. 2. DNA synthesis in synchronized human smooth muscle cell culture after 24 hours of 
incubation with different concentrations of nicotine or cotinine dissolved in medium M199 
supplemented with 15% fetal bovine serum. Values indicate percent of SH thymidine incorpo- 
ration compared with values obtained with M199/15% fetal bovine serum in absence of 
nicotine or cotinine. Values represent mean of three to five observations, with +SEM indicated 
by vertical bars (*p < 0.05). 
and the primary antibodies were added and incu- 
bated for 30 minutes. In the next step the link anti- 
body was applied followed by washing and incuba- 
tion with labeled antibody. A substrate solution of  
3-amino,9-ethytcarbazole was then added. Finally, 
the cells were counterstained with Mayer's hematox- 
ylin-eosin. 
Assay o f  DNA synthesis. Confluent SMC were 
trypsinized, and cells vcere seeded at a density of  
1.8 × 104 cells per well in 24 multiwell dishes. The 
cells were incubated in GM for 24 hours, and they 
were allowed to attach and spread before synchroni- 
zation. The cells were synchronized in M199 with 
0.1% FBS (no-grovcth medium, NG) for 48 hours, 
ensuring that greater than 90% of  cells were in Go/  
GI. 3H thymidine uptake was used as a measure of  
DNA synthesis. The cells were washed with sterile 
PBS and then growth-stimulated with 1 ml of  GM or 
NG containing nicotine or cotinine at concentrations 
ranging from 10 -9 to 10 -6 mol /L .  Two llCi of  3H 
thymidine was added to each well. The plates were 
incubated at 37 ° C for 24 hours before the superna- 
tants were discarded and the wells washed with cold 
PBS. Protein precipitation was done with 5% trichlo- 
roacetic acid for 45 minutes at 4 ° C. The wells were 
again rinsed with cold PBS and were then incubated 
overnight in 0.5 ml of  0.25 mol /L  sodium hydrox- 
ide. The contents of  each well were added to 10 ml 
of  scintillation cocktail along with 0.5 ml of  PBS 
rinse. The radioactivity was determined in a liquid 
scintillation counter over a 10-minute time period. 
Each test concentration was run in quadruple, and 
the results were averaged. Cells incubated with GM 
and NG without nicotine or cotinine were used as 
control samples. 
Cell prol i ferat ion studies. To study the effect 
of  nicotine and cotinine on cell proliferation, vascular 
SMC were plated at a density of  1.8 × 104 cells per 
well in 24 multiwell dishes and were incubated as 
described previously. After a 48-hour synchroniza- 
tion in NG, the cells were growth-stimulated with 1 
ml of  GM or NG containing nicotine or cotinine at 
concentrations ranging from 10 -9 to 10 -6 mol /L .  
The cultures were incubated at 37 ° C for 4 days, and 
the medium was changed every 48 hours. At the end 
of  the study the cells were trypsinized and counted in 
a cell counter (Elzone Particle Data Inc., Elmhurst, 
Ill.). There were four wells per test concentration, 
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Fig. 3. Cell proliferation i human smooth muscle cell cultures timulated by different con- 
centrations of nicotine or cotinine dissolved in M199 supplemented with 0.1% fetal bovine 
serum. At day 4, cell cultures were trypsinized and counted. Values represent mean of three or 
four observations, with +SEM indicated by vertical bars (*p < 0.05). 
and each well was counted in duplicate. Control 
samples were incubated with corresponding media 
but without nicotine and cotinine. 
In a different set of experiments designed to study 
the kinetics of SMC proliferation, the cells were 
treated as described previously with the following 
exceptions. A single concentration of nicotine (10 -s 
tool /L)  and cotinine (10 -s mol /L)  was chosen for 
its optimal effect on cell proliferation and for its 
approximation to the physiologic levels. Cells were 
counted at days 2, 4, and 6 after being released from 
the G0/G l phase. There were four wells per test 
concentration, and each well was counted in dupli- 
cate. Cells incubated without nicotine or cotinine 
were used as control samples. 
Statistical analysis. The results of  many experi- 
ments were pooled and expressed as the percent 
change compared with the appropriate control sam- 
ple (mean + SEM). Results were analyzed by analysis 
of  variance (ANOVA) and by Student's t test. The 
significance was determined by p < 0.05. 
RESULTS 
Characterization o f  cells. The cultured cells 
were characterized as SMC by atypical "hills and 
valleys" growth pattern at confluence. In addition, 
they stained positively with et-actin antibodies. No 
staining was observed with antibodies against von 
Willebrand factor, demonstrating the absence of en- 
dothelial cells in the cultures. These observations 
were consistent hroughout he different passages 
used in the experiments. 
Effect o f  nicotine and cotinine on DNA syn- 
thesis. Nicotine and cotinine dissolved in serum- 
free medium and growth medium were analyzed for 
their ability to induce DNA synthesis in subconfluent 
human SMC cultures. In serum-free medium both 
agents stimulated DNA synthesis in concentrations 
ranging from 10 -9 to 10 -6 mol /U  In concentra- 
tions less than 10 -6 mol /L  there was a significant 
increase in DNA synthesis compared with the control 
sample. The maximum effect of both nicotine and 
cotinine was seen at a concentration of 10 -7 mol /L  
(133 and 148% of control samples, respectively). 
Cotinine was consistently a much more potent stim- 
ulatory of DNA synthesis in SMC than nicotine (Fig. 
1). The stimulatory effect of  cotinine was signifi- 
cantly stronger when the drug was dissolved in 
growth medium containing 15% FBS. Maximum ef- 
fect was seen at concentration of 10 -9 mol /L  (227% 
of control). However, both drugs in all concentra- 
tions tested caused significant stimulation of DNA 
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Fig. 4. Cell proliferation i human smooth muscle cell cultures timulated by different con- 
centrations of nicotine or cotinine dissolved in M199 supplemented with 15% fetal bovine 
serum. At day 4, cell cultures were trypsinized and counted. Values represent mean of three or 
four observations, with +SEM indicated by vertical bars (*p < 0.05). 
synthesis in SMC compared with the control samples 
(Fig. 2). 
Mitogenic activity o f  nicotine and cotinine in 
human SMC. To investigate the effect of nicotine 
and cotinine on SMC proliferation, each drug in final 
concentrations ranging from 10 -9 to 10 -6 mol /L  
was added to subconfluent SMC cultures. In serum- 
free medium nicotine lacks mitogenic activity. In 
contrast, cotinine at concentrations of 10 -7 mol /L  
and 10 -6 mol /L  caused a significant increase in cell 
number compared with the control samples (approx- 
imately 110%) (Fig. 3). However, each drug showed 
mitogenic activity at some concentrations when dis- 
solved in medium containing 15% FBS (Fig. 4). Co- 
tinine at concentration 10 -6 mol /L  appeared to be 
toxic to SMC. 
The kinetics of  SMC proliferation i  the presence 
of nicotine and cotinine at a concentration of  10 -8 
mol /L  dissolved in both serum-free and growth me- 
dia were studied at days 2, 4, and 6. In NG no 
significant increase in cell number was noted over the 
study period. However, both agents in GM caused 
consistent, significant increase in cell count (p < 
0.0001) compared with the control group (Fig. 5). 
The cell mitogenic effect of nicotine and cotinine was 
first seen after day 2 of  the incubation period. 
DISCUSSION 
Cigarette smoking has been linked to the devel- 
opment of atherosclerosis and to the failure of  aor- 
tofemoral and infrainguinal arterial graft. 8,9 Re- 
cently, smoking has been identified as the most 
important risk factor for occlusion of  both vein and 
prosthetic femoropopliteal grafts within the first year 
after operation3 ,6-9,12 The mechanism by which 
smoking alters the formation and progression of  in- 
timal hyperplasia that results in graft failure is not 
clearly understood. Although the short-term effects 
of smoking appear to be caused by the effects of  
nicotine on the neuroendocrine and cardiovascular 
systems, the long-term effects may be due to cotin- 
ine, nicotine's major metabolite. ~3-17 Cotinine is 
formed in the liver from the oxidation of  nicotine by 
the cytochrome P-450 system. It has a very long 
biologic half life, approximately 10 times longer than 
nicotine. The plasma concentration of  cotinine 
ranges from 5.9 to 15.0 × 10 -7 mol /L  in active 
smokers and less than 1.1 × 10 -7 mol /L  in passive 
smokers, ls,26 In contrast, these values are 6.2 to 
19.0 × 10 -s mo l /L  for nicotine in active smokers 
and less than 3.3 × 10 -8 in passive smokers3 s,27 
Experimental study in rats revealed that intrave- 
nous administration of nicotine produce significant 
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Fig. 5. Cell proliferation in human smooth muscle cell culture stimulated by nicotine or 
cotinine at concentration 10-8 mol/L dissolved in M199 supplemented with 15% fetal bovine 
serum. Cell culture was trypsinized and counted at day 2, 4 and 6. Values represent mean of 
three observations, with _+SEM indicated by vertical bars. 
increase in circulating carcasses of  endothelial cells, 
indicating desquamation. 18 In humans smoking of 
two cigarettes increased circulating endothelial cell 
carcasses by 50%. 19 It is interesting that even passive 
smoking increased circulating endothelial cell car- 
casses in a manner comparable to that observed with 
active smoking. 2° In an experimental rterial injury 
model in rats, Krupski et al. 2: demonstrated that 
serum nicotine levels similar to those observed in 
human smokers accelerated development of intimal 
hyperplasia. Thyberg, 22 using rat SMC cultures, 
showed that nicotine induced DNA synthesis and 
modulation of the smooth muscle cell from contrac- 
tile to synthetic phenotype. Furthermore it has been 
shown in human trophoblast in vitro that nicotine 
and cotinine prevented conversion of testosterone to
estrogen as a result of direct inhibition of aromatase 
activity. 23 This may explain why women smokers 
have lower levels of circulating estrogen than non- 
smokers. 14 Estrogen has been shown to have a pro- 
tective effect against he development of atheroscle- 
rosis in human and intimal hyperplasia fter arterial 
injury in mice. 24 Smoking has also been shown to 
affect platelet aggregation, leukocyte adhesion, lipid 
metabolism, and the permeability of the arterial wall 
to fibrinogen. 12,25,26,28,29 
We have recently shown that cotinine stimulated 
expression and secretion of endothelin-1 in the large 
vessel endothelial cells in tissue culture? ° This result 
is particularly interesting considering recent findings 
by us and others showing that endothelin is a mito- 
gen tbr SMC in vitro and promotes development of
intimal hyperplasia in rat carotid artery injury mod- 
el. 31,32 Thus it is possible that smoking may partially 
exert its mitogenic and atherogenic effects through 
an endothelin-mediated mechanism. In this study we 
evaluated the direct effect of nicotine and cotinine on 
DNA synthesis and SMC proliferation in vitro. The 
range of concentrations of nicotine and cotinine used 
include those found in the plasma of active and 
passive smokers. The results revealed that both com- 
pounds stimulated DNA synthesis in a dose-depen- 
dent manner, but the effect was more prominent 
when the conditioned medium was supplemented 
with serum. Similarly, the cell proliferation study 
showed that cotinine exerted only a minor stimula- 
tory effect in the presence of low serum concentra- 
tion, whereas both compounds significantly en- 
hanced cell proliferation when dissolved in the 
medium containing 15% FBS. Thus the mitogenic 
effects of nicotine and cotinine were mediated by 
factors present in the serum. We hypothesize that 
both compounds either upregulate the production of 
growth factors essential for cell proliferation or en- 
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hance expression o f  their  receptors on  cell mem-  
branes. General ly,  cot in ine was a more  potent  mi to -  
gen for SMC than n icot ine and signif icantly 
p romoted  DNA synthesis in SMC even in concentra-  
t ions seen among plasma o f  passive smokers.  
In  summary,  we have presented a potent ia l  mech-  
anism by which  c igarette smok ing  may promote  de- 
ve lopment  o f  int imal  hyperplasia nd contr ibutes  to 
the poor  results after bypass graft ing. A l though the 
molecu lar  mechan isms for this phenomenon are un-  
known,  an upregu la t ion  o f  certain growth-enhanc-  
ing processes appear to be involved.  We are current ly  
invest igat ing this hypothesis  in our  laboratory.  
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